| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9481 |
| Human Intestinal Absorption | HIA+ | 0.9973 |
| Caco-2 Permeability | Caco2+ | 0.7552 |
| P-glycoprotein Substrate | Substrate | 0.6158 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.5569 |
| Non-inhibitor | 0.9246 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7415 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8879 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8240 |
| CYP450 2D6 Substrate | Non-substrate | 0.9375 |
| CYP450 3A4 Substrate | Substrate | 0.7402 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8666 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9529 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9516 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9295 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8850 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9344 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9271 |
| Non-inhibitor | 0.8517 |
| AMES Toxicity | Non AMES toxic | 0.9471 |
| Carcinogens | Non-carcinogens | 0.9578 |
| Fish Toxicity | High FHMT | 0.9926 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8642 |
| Honey Bee Toxicity | High HBT | 0.8326 |
| Biodegradation | Not ready biodegradable | 0.9322 |
| Acute Oral Toxicity | III | 0.5650 |
| Carcinogenicity (Three-class) | Non-required | 0.4811 |